Oxurion NV
@oxurion.com
Oxurion (Euronext Brussels: OXUR) is a Belgian company building a leading European group of contract research organisations through buy-and-build acquisitions.
Oxurion NV's Company Logos
Oxurion NV's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#0C284F
Downriver
12, 40, 79
215, 74, 18
85, 49, 0, 69
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#061D0F
Palm Green
6, 29, 15
143, 66, 7
79, 0, 48, 89
About Oxurion NV
Oxurion is a leading brand dedicated to developing innovative treatments to improve and preserve vision for patients with diabetic macular edema (DME). They are committed to addressing the needs of up to 50% of DME patients who do not respond well to anti-VEGF therapies. At Oxurion, they are developing next-generation ophthalmic therapies, with their flagship product being THR-149.
This breakthrough treatment is a potent PKal inhibitor that has shown promising results in patients who do not respond to current treatment options. With a team of experienced professionals and a strong network of scientific advisors, Oxurion is at the forefront of pioneering treatments for diabetic eye disease. They are constantly working towards improving the lives of patients and pushing the boundaries of ophthalmic medicine.
If you are an investor interested in learning more about THR-149 and Oxurion, they provide detailed information on their website. Get in touch with them to know more about their groundbreaking innovations and contribute to the future of vision care. Your vision is Oxurion's vision, and together, they strive to make a difference
Related Brands
Tags
Clinical research organizations
Clinical data management
Biostatistics and biometrics
Regulatory affairs for clinical trials
Pharmacovigilance and real-world evidence
